The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
Jun 1, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Apotex’s planned IPO values generic drug maker at $5-billion
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.265 · RIGHT
Ensemble
0.133 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.049
3,141 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
CHRIS HANNAY PUBLISHED JUNE 1, 2026 Report an editorial error Report a technical issue Editorial code of conduct Tickers mentioned in this story Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 02/06/26 4:00pm EDT. Symbol Name % change Last DFY-T Definity Financial Corporation +2.23% 67.3 Follow related authors and topics CHRIS HANNAY FOLLOW INITIAL PUBLIC OFFERINGS (IPOS) FOLLOW PHARMACEUTICAL INDUSTRY FOLLOW STOCK MARKET NEWS FOLLOW TORONTO STOCK EXCHANGE (TSX) FOLLOW Authors and topics you follow will be added to your personal news f…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jun 2, 2026